Correlation Between Viatris and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Viatris and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Innate Pharma, you can compare the effects of market volatilities on Viatris and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Innate Pharma.
Diversification Opportunities for Viatris and Innate Pharma
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viatris and Innate is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Viatris i.e., Viatris and Innate Pharma go up and down completely randomly.
Pair Corralation between Viatris and Innate Pharma
Given the investment horizon of 90 days Viatris is expected to generate 0.44 times more return on investment than Innate Pharma. However, Viatris is 2.29 times less risky than Innate Pharma. It trades about 0.05 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.05 per unit of risk. If you would invest 1,157 in Viatris on September 3, 2024 and sell it today you would earn a total of 152.00 from holding Viatris or generate 13.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viatris vs. Innate Pharma
Performance |
| Timeline |
| Viatris |
| Innate Pharma |
Viatris and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viatris and Innate Pharma
The main advantage of trading using opposite Viatris and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |